Additionally, some RA-obstructive CAD patients were treated with statins, antiplatelet agents, β-blockers, renin-angiotensin-aldosterone system inhibitors, angiotensin-converting enzyme inhibitors, and other vasodilators. This evidence concerns the gene ACE and rheumatoid arthritis.